awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q40863917-E4A3566D-A157-4574-AA8E-17E724833AA3
Q40863917-E4A3566D-A157-4574-AA8E-17E724833AA3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40863917-E4A3566D-A157-4574-AA8E-17E724833AA3
(90)Y-labelled anti-CD22 epratuzumab tetraxetan in adults with refractory or relapsed CD22-positive B-cell acute lymphoblastic leukaemia: a phase 1 dose-escalation study.
P1476
Q40863917-E4A3566D-A157-4574-AA8E-17E724833AA3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40863917-E4A3566D-A157-4574-AA8E-17E724833AA3
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
2106cc4de2c159fe50c0cc7eb8e884e4d051753c
P1476
(90)Y-labelled anti-CD22 eprat
......
phase 1 dose-escalation study
@en